Skip to content
Research Article Open access CC BY 4.0

Method Development and Validation of a Specific Stability Indicating RP-HPLC Method for Molnupiravir API

Gundapaneni Ravi Kumar, Borra Suman Babu, Rayala Rama Rao, Vadde Megha Vardhan, V. D. N. Kumar Abbaraju

Journal of Pharmaceutical Research International · pp. 3026–3035 · Published 27 Dec 2021

10.9734/jpri/2021/v33i60B34973

Abstract

A simple, accurate, isocratic stability indicating RP‐HPLC method was developed for the determination of Molnupiravir in bulk drug. This RP-HPLC was achieved on “Waters 2695 using an Agilent Zorbax Eclipse C18 (250 mm × 4.6 mm × 5 µm)” column with the mobile phase consisting of 30 mM, ammonium phosphate monobasic and Methanol in the ratio of 47:53 %v/v. The stress testing of Molnupiravir was carried out under acidic, alkaline, oxidative, thermal, and photolytic conditions and formed degradation products were well resolved from Molnupiravir API (active pharmaceutical ingredient). The suggested approach was validated according to ICH (International Council on Harmonisation) principles, and all of the validation parameters' findings were within acceptable limits. The method was proven to be appropriate for quality control of Molnupiravir in bulk and pharmaceutical dose forms, as well as stability testing.

Assay stress studies validation molnupiravir

Cited by 6

Green Solvent-Based UV Spectrophotometric Technique for Quantifying Molnupiravir in Bulk and Pharmaceutical Formulation

Gandi Anusha, Shaik Nargiz, Allu Sireesha · Research Journal of Pharmacy and Technology · 2024

5 Years of Covid19—do antiviral drugs and their metabolites pose a danger to the aquatic environment?—a short review

Melanie Voigt, Martin Jaeger · Toxicological & Environmental Chemistry · 2025

Development and validation of a new stability indicating RP-UFLC method for the quantification of Molnupiravir

Asia Asia, Revu Baby Nalanda · Research Journal of Pharmacy and Technology · 2025

Sustainable Stability-Indicating spectra manipulations for the concurrent quantification of a novel Anti-COVID-19 drug and its active Metabolite: Green profile assessment

Michael Gamal Fawzy, Ebraam B. Kamel · Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2023

Article metrics

Real usage data collected on this platform.

1

Page views

0

PDF downloads

0

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.